Expertise in
1
conditions

Xin M. Song

600# TianHe Road, 
Guangzhou, CN 
Expertise in
1
conditions
600# TianHe Road, 
Guangzhou, CN 

Overview

Xin Song practices practicing medicine in Guangzhou, China.

Ms. Song is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Epididymitis, Melanoma, Hydrocephalus due to Congenital Stenosis of Aqueduct of Sylvius, Vitrectomy, and Endoscopy.

She is actively involved in clinical research, co-authoring 219 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

600# TianHe Road, Guangzhou, 510630, China
Other Locations
185, East Lake Road, Wuhan, 430071, China
516 Jungong Road, Shanghai, 200093, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Controlled, Multi-center, Phase III Clinical Study to Investigate Recombinant Humanized PD-1 Monoclonal Antibody Injection (JS001) Versus Dacarbazine as the 1st-line Therapy for Unresectable or Metastatic Melanoma
A Randomized, Controlled, Multi-center, Phase III Clinical Study to Investigate Recombinant Humanized PD-1 Monoclonal Antibody Injection (JS001) Versus Dacarbazine as the 1st-line Therapy for Unresectable or Metastatic Melanoma
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Biological
Study Drugs: JS001, Dacarbazine
Study Phase: Phase 3
A Phase II, Open, Multi-center and Single Arm Study Investigating Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Injection in Patients With Locally Advanced or Metastatic Melanoma and Standard Treatment Failure
A Phase II, Open, Multi-center and Single Arm Study Investigating Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Injection in Patients With Locally Advanced or Metastatic Melanoma and Standard Treatment Failure
Enrollment Status: Unknown
Publish Date: September 30, 2020
Intervention Type: Biological
Study Drug: Humanized Anti-PD-1 Monoclonal Antibody Toripalimab
Study Phase: Phase 2
View 1 Less Clinical Trial

219 Total Publications

Integrated Phenotypic and Whole-Genome Analysis of Enterococcus hirae HI3 Isolated from Hu Sheep Jejunum Supports Its Potential as a Ruminant Probiotic Candidate.
Integrated Phenotypic and Whole-Genome Analysis of Enterococcus hirae HI3 Isolated from Hu Sheep Jejunum Supports Its Potential as a Ruminant Probiotic Candidate.
Journal: Microorganisms
Published: May 28, 2026

Frequently Asked Questions about Xin M. Song

Is Xin M. Song a top-rated expert for Epididymitis?

MediFind is an objective health platform that identifies experts based on real-world data. Xin M. Song is classified as an Advanced expert for Epididymitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Xin M. Song participate in research or clinical trials?

Yes. Xin M. Song has published 219 articles and abstracts on conditions like Epididymitis. You can view a list of Xin M. Song's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Song's expertise for a condition
ConditionClose
      View All 28 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile